Archives: Resources

Amyloidosis cardiologist, Dr. Mazen Hanna discusses the function of implantable, electronic devices in cardiac management of amyloidosis patients.

Dr. Hanna provides clarity about which devices exist to assist patients, and the role they serve in heart maintenance. This includes devices for atrial fibrillation management, such as a watchman device, in addition to the indications for a pacemaker or ICD device.

Original Presentation Date:
February 08, 2024

Key Webinar Highlights:

0:00 — Introduction

3:18 — Start of presentation

4:27 — Atrial fibrillation diagram

6:56 — Atrial fibrillation in cardiac amyloidosis

10:02 — Atrial fibrillation: anticoagulation

12:06—  Transesophageal echocardiogram (TEE)

13:13 — Intracardiac thrombosis in cardiac amyloidosis

16:08 — CAA occlusion

19:00 — Atrial fibrillation ablation

20:54 — Atrial fibrillation rate control

21:59 — Atrial fibrillation rhythm control

23:06 — Conduction

25:38 — How a pacemaker works

27:57 — Impact of RV pacing on outcomes in ATTR cardiac amyloidosis

28:29 — Cardiac resynchronization therapy in ATTR cardiac amyloidosis

30:17 — Ventricular Arrythmias in cardiac amyloidosis

31:37 — Primary prevention ICD in ATTR cardiac amyloidosis

32:41 — Standard protocol

33:52 — Guidelines for defibrillators

34:37 — MEMs based pressure sensor for monitoring pulmonary artery pressures

36:55 — Presentation summary

38:20 — Start of Q and A session

Contact Us:

Call +1 (617) 467-5170

Email us at arc@arci.org